Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction.
Mesh Terms:
Angiotensin-Converting Enzyme 2, COVID-19, Ceftazidime, Humans, SARS-CoV-2, Spike Glycoprotein, Coronavirus
Angiotensin-Converting Enzyme 2, COVID-19, Ceftazidime, Humans, SARS-CoV-2, Spike Glycoprotein, Coronavirus
Acta Pharmacol Sin
Date: Sep. 01, 2023
PubMed ID: 36944800
View in: Pubmed Google Scholar
Download Curated Data For This Publication
246283
Switch View:
- Interactions 1